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Confounding factors in the assessment of delivered hemodialy- physiological role. The toxicity might be due to the syner-
sis dose. A satisfactory dialysis patient’s outcome results from gism of specific toxic effects when several components
an effective and personalized therapy. However, the higher are brought together. However, the absence of any reli-the prescribed efficiency, the more likely it is that the prescribed
able and universally acceptable markers has preventeddose is incorrectly administered. Avoiding discrepancies be-
tween the prescribed and delivered doses calls for a continuous the standardization of dialysis therapy until urea was
surveillance, from urea kinetics to urea biosensors. An unexpect- elected as a marker of patient outcome [6]. This choice
edly low efficiency result may affect several patients or may has been ratified by the National Cooperative Dialysisjust be limited to the individual patient. An inadequate calibra-
Study [7], which assessed the role of the blood ureation of blood and dialysate pumps or manufacturing defects in
blood tubings or needles may be responsible for a more diffuse nitrogen concentration along with the length of the dial-
phenomenon. The most frequently detected factors in the indi- ysis session as parameters of the adequacy in long-term
vidual patient are poor vascular access, recirculation, decreases dialysis therapy. Nowadays, some evidence has confirmed
in dialyzer performance and insufficient anticoagulation. How-
these early insights, and it has been suggested that theever, urea removal per se is not enough to satisfy all the assump-
dialysis patient’s outcome may be related to dialysis dosetions underlying an adequate dialysis therapy. Indeed, dialysis
adequacy is achieved by way of a complex combination of and nutritional status [8].
numerous elements transcending urea removal alone: acidosis In terms of dialysis dose, the response is usually moni-
correction, the achievement of dry body weight, fluid and elec-
tored by means of urea kinetic modeling (UKM) andtrolyte homeostasis, good blood pressure control, overall bio-
efficiency-related quantities: (1) The Qt, calculated as acompatibility, anemia and malnutrition correction, and finally,
a customized schedule together with treatment duration. product of the blood flow rate and the treatment time,
represents the total blood volume cleared during the
dialysis session. (2) The Kt, a product of instantaneous
The question of what actually constitutes adequate clearance and treatment time, indicates the absolute de-
dialysis for uremic patients is a controversial and debated puration achieved during the treatment. (3) The Kt/V is
issue within the dialysis community [1–4]. a dimensionless index reflecting how the achieved depur-
The first point in discussing dialysis adequacy concerns ation is adapted to the individual patient, with V being
the substances that are responsible for uremic symptoms the patient urea distribution volume.
and thus are useful as markers of uremic status [5]. Small However, regardless of the method and the formula
molecules, such as urea, creatinine and uric acid, or mid- chosen to prescribe the therapy, the fact remains that
dle molecules like b2-microglobulin, indoles, amines, and the delivered therapy may diverge completely from the
hormones normally retained and accumulated in uremia, prescribed one. The extracorporeal circuit is strewn with
have been considered to be the cause of uremic syn- weak spots such as blood lines, needles, dialyzer, hepa-
drome. However, there is no absolute evidence proving rinization, and vascular access (Fig. 1). When one of
that any one of them is the sole cause of the uremic these factors is altered, dialysis efficiency could be com-
status [5, 6]. Indeed, the search for The Uremic Toxin is promised. Three main aspects should be examined in
beginning to look like the quest for the Holy Grail, in order to sum up the confounding factors involved in the
other words, endless. As a matter of fact, the entire delivery of the dialysis dose: dialyzer solute transport,
spectrum of accumulated products may play a patho-
vascular access function, and technical or methodological
trouble spots.
Urea kinetic modeling itself may have some weak con-Key words: dialysis adequacy, access recirculation, urea kinetic model-
ing, urea biosensors. ceptual and practical points that may be responsible for
an erroneous evaluation of variables such as the ureaÓ 2000 by the International Society of Nephrology
S-19
Santoro: Confounding factors in dialysis therapy deliveryS-20
Fig. 1. Schematic representation of the extra-
corporeal circuit and the weak points that
could be critical for the efficiency of dialysis
therapy.
generation rate, the urea volume distribution, and the where 0 indicates the predialysis value. Furthermore, the
single-pool concept may even be used to measure theprotein catabolic rate [7–10].
fractional clearance of the urea distribution volume
(Kd 3 Td/V), thus providing a measure of the individual-UREA KINETIC MODELING
ized dialysis dose. When the dialyzer clearance, Kd, and
Urea kinetics during dialysis and interdialysis may be the treatment time, T, are known, the value of urea distri-
described by single- or double-pool models [7–10]. Total bution volume, V, can also be measured or estimated.
water volume representative of the urea volume distribu- Different urea models, both monocompartmental and
tion has, in general, been assumed to be constant. Total bicompartmental, have been put forward over the last
water volume may be considered time variant in order 10 years [7–12]. Each one presents arguments for and
to take account of water loss during dialysis and water against the theory and the practice. Methods based on
intake during interdialysis. In the single-pool urea model monocompartmental models systematically underesti-
(Fig. 2A), the amount of body urea (x) is related to urea mate the urea distribution volume [13]. An overcompen-
generation (Gu) and urea removal (Kd). Moreover, the sation can be obtained by the urea mass balance method
urea concentration is derived from the ratio of the urea if the re-equilibrated urea blood concentration, taken
mass (x) and the urea diffusion volume (V). The urea one hour after the end of dialysis, is used instead of the
volume may be assumed to be constant or linearly de- urea dialysis concentration measured immediately at the
creasing during the dialysis with a slope equal to the end of the dialysis session. Furthermore, the techniques
mean ultrafiltration rate (Qf) starting from an initial neglecting dialysis weight loss and dialysis urea genera-
value V0. The urea production (Gu) varies in relation tion overestimate the volume as a result of a compensa-
to the patient’s protein catabolic rate. The elimination tion between two errors. Kinetic models overestimate
process is expressed by the Kd coefficient, which summa- urea production, while those based on mass balance pro-
rizes two different values: the dialyzer clearance (Kd) vide more reliable results in this sense [14].
during the treatment and the residual urea clearance Among the double-pool models, which are definitely
(Kr) in the interdialysis period. In the single-pool model, more complicated, the variable volume double-pool
the dynamic mass balance is then expressed by the fol- method provides the most reliable rough estimate for
lowing equation: the urea volume and urea generation rate [9, 11]. Conse-
quently, this method is the most suitable one for calculat-dx
dt
5 2
Kd
V
· X 1 Gu ing the exact protein catabolic rate [11].
Nevertheless, in routine dialysis, a simple fixed model
The parameters characterizing the single-pool model are with a reasonable estimate or measurement of dialyzer
the urea production Gu and the initial total urea volume clearance produces satisfactory results. In everyday clini-
cal experience, much easier indexes are employed, likeV0, while the initial condition is estimated by X0 5 C0/V0,
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Fig. 2. Diagrammatic representation of sin-
gle-pool (A) and double-pool (B) models of
urea kinetics. Abbreviations are: Gu, urea
production rate; X, urea body mass; V, urea
diffusion volume; X1, intracellular urea com-
partment; V1, intracellular urea diffusion vol-
ume; X2, extracellular urea compartment; V2,
extracellular urea diffusion volume; Kc, inter-
compartment urea transfer coefficient; Kd, dia-
lyzer clearance; Kr, residual renal clearance.
the well-known Kt/V or the equivalent renal clearance membrane, the geometry, the flows, and the pressures
in the blood and the dialyzate compartment. Dialyzer(EKR), which was formulated by Casino and Lopez [15].
dysfunction during the treatment may be caused by struc-EKR is a continuous equivalent parameter accounting
tural or functional factors. Dialyzer clotting may mark-for the differing relationship between clearance and ac-
edly reduce diffusion in hollow fibers. Several factors,tual solute removal among disparate therapies. A practi-
such as inadequate heparinization, poor blood flow, highcal alternative to Kt/V is the urea reduction ratio (URR),
venous pressure, transfusion of blood during dialysis,the percentage of urea decline during a single treatment
and improper priming, may favor complete or partial[8]. The URR, which is easily calculated from two urea
dialyzer clotting. Changes in blood and dialysis flow maysamples, one at the beginning and the other at the end
modify the solute clearance, thus reducing the urea re-of the dialysis session, is correlated with Kt/V and the
moved. The blood pump should be set at a predefineddialysis outcome [16]. However, this measurement does
speed within a few minutes of starting dialysis and shouldnot consider the effect of the ultrafiltration and the dial-
not be modified during the session. Slow “turn up” atysis duration. Several simple and practical formulae have
the beginning of dialysis or slow “turn down” at the endbeen proposed over the last few years to calculate dialysis
may decrease the amount of the dialysis delivered toefficiency without stumbling into wrong evaluations even
the patient, especially if treatment times are short. Thein nonstandard dialysis conditions (abstract; Garred et
effective clearance may be subject to unexpected dropsal, ASAIO J 40:719, 1994) [17]. Although these simplified
in patients with hypotension (Fig. 3). A blood flow reduc-formulae are convenient, their use alone as opposed to
tion during the blood pressure drop phase diminishesurea kinetic models results in the loss of the functions
the urea mass supplied to the dialyzer. Furthermore,offered by UKM, such as the calculation of the modeled
hypotension may affect the dialysis efficiency by inducingurea distribution volume, tracking it over time, or the
regional blood flow distribution with underperfusion ofcomparison of the modeled volume with the one ob-
some tissue districts. Reductions in blood pressure andtained by anthropometric formulae.
in cardiac output may have repercussions in the vascular
access flow, thus favoring recirculation. Finally, the slow-
DIALYZER SOLUTE TRANSPORT ing of the blood flow and the ultrafiltration turn off
Knowledge of the urea transfer urea coefficient (KoA) interfere with the diffusive and convective clearance.
for a dialyzer is important in prescribing the dialysis dose. Most dialyzer manufacturers report clearance values
During dialysis, dialyzer performance is affected by sev- based on in vitro studies using aqueous solutions. This
methodology may overestimate the in vivo delivery byeral factors such as the properties and structure of the
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Fig. 3. Factors and mechanisms that could in-
duce reductions in effective clearance during
dialysis-related hypotension episodes.
as much as 20%. In vivo measurement of the clearances tional clearance as well as for Kt/V [20]. By measuring
solute losses instead of dialyzer clearance, the focusrequires the evaluation of the solute removal in the dialy-
zate, the solute concentration in the incoming blood, and could be shifted from the dialyzer performance to patient
outcome and to his/her nutrition level. Furthermore,the accurate measurement of the blood and dialyzate
flows. Minimal errors in each of these variables may since the evaluation is performed in real time, monitored
dialysis can be tailored to assure the adequacy of eachinduce great errors in clearance calculation. An indirect
method has recently been proposed to estimate the dia- dialysis treatment. Some urea sensors employ conductiv-
ity cells located in a blood ultrafiltrate stream. With thislyzer clearance by means of the determination of ionic
dialysance [18]. The ionic dialysance can easily be mea- biosensor, the continuous surveillance of the urea-time
profile and the identification of factors leading to discrep-sured with two conductivity cells placed both at the out-
flow and at the inflow of the dialysate. This measure is ancy between prescribed and delivered Kt/V may be
obtained [24]. Recirculation can be measured by simpleindependent of the recirculation and provides a satisfac-
tory determination of effective urea clearance [19]. How- interruption of the diffusion process or by the infusion
of a bolus of saline solution into the arterial and venousever, the best solution to the problem of the measure-
ment of the delivered dialysis dose is the urea biosensor line. Postdialysis urea rebound and intercompartmental
urea mass transfer coefficient (Kc) can also be measuredplaced at different sites of the extracorporeal circuit
[20–24]. The urea sensor provides an additional advan- by the analysis of the intradialytic trends. Patients with
low Kc, particularly during high efficiency and short treat-tage by producing a real-time profile of the dialysate or
of the blood urea concentration [23, 24]. The use of the ments, show both sudden and large imbalances between
the low and rapid transfer compartments. Under thesebiosensors could revolutionize the quantitation of the
dialysis therapy, shifting it from measures of clearance conditions, we have found very low values of end-dialysis
urea concentrations and postdialysis rebounds of up toand concentration to measures of mass. Dialysate-based
urea sensors provide a continuous display of dialyzed 30 to 40%. The practical consequence of all of this is an
increased risk of underdialysis caused by an overestima-urea and Kt/V achieved to a current point, as well as
current patient clearance [24]. The solute removal index, tion of the Kt/V.
In the final analysis, urea biosensors may have manyin fact, has been suggested as a substitute for the tradi-
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Fig. 4. Continuous recording of ultrafiltrate urea concentration by Fig. 5. Reduction in effective urea clearance with different percentagemeans of a urea biosensor [24] during paired filtration dialysis (continu- of recirculation. Mathematical formula to calculate the effective clear-ous line). The dotted line represents the urea profile corrected for the ance (Keff) in the presence of access recirculation (R) and prescribedaccess recirculation. C1 and C2 represent the urea concentration in blood flow rate (Qb).presence and absence of recirculation. C1 represents the urea concentra-
tion during dialysis (diffusion plus convection) and in the presence of
a possible recirculation. C2 is the change in the urea concentration
observed when the diffusion process is stopped and the effect of the
recirculation on the urea concentration is offset. namic venous dialysis pressure monitoring, color-flow
Doppler, access flow evaluation, fistulogram, and above
all, recirculation detection [26]. Recirculation is usually
evaluated by means of the simultaneous measurementadvantages, but more studies are needed to prove
of the urea concentration in both the arterial and venouswhether the routine use could be of clinical benefit.
sides of the extracorporeal circuit and a peripheral vein
of the opposite arm. However, the measurement of the
VASCULAR ACCESS FUNCTION recirculation using the three-sample technique is often
The vascular access is the real Achilles’ heel of dialysis inaccurate and does not allow us to distinguish between
efficiency. An excellent access allows for the achieve- vascular access recirculation and cardiopulmonary recir-
ment of a high blood flow without the risk of recircula- culation [27]. The slowing or stopping of the blood flow
tion. Venous stenosis or the placement of a tourniquet before the withdrawal of the blood sample without a
on the upper arm to normalize the apparent fistula blood reduction in urea due to recirculation allows for a more
flow (while actually creating an external equivalent of accurate determination of the access recirculation. How-
stenosis) may favor access recirculation. The stenosis ever, even this three-sample technique is an extemporary
effect is more evident in the presence of a high blood measurement generally performed at the beginning of
flow and may thwart the increment in the flow rate. the hemodialysis session and without taking into account
Recirculation may also occur if the venous needle is any possible increase appearing throughout the treat-
inadvertently placed downstream to the arterial needle. ment (ascribable to changes in blood viscosity or in ac-
Using the double lumen catheter at a high blood flow cess flow). Online and noninvasive measurement would
rate, the risk of recirculation is extremely elevated. Re- be preferable in order to quantitate the recirculation
circulation reduces the efficiency by decreasing the in- during any time of the dialysis session and with the
tradialytic urea profile supplied to the dialyzer (Fig. 4). chance to repeat the measurement as one wishes [20].
This phenomenon may be easily demonstrated with the Saline or dialysis fluid (via the dialyzer) can be injected
use of a biosensor placed in the blood ultrafiltrate into the venous line, and its appearance detected in the
[24, 25]. The online measurement of the recirculation arterial line reveals the recirculation [24, 25]. The princi-
allows the real-time correction of the urea profile. As ple of thermal or optical dilution can also be employed
online devices for measuring recirculation are not avail- [20, 28, 29].
able, the reduction in effective clearance may be calcu-
lated by specific formulae (Fig. 5). Recirculation may
TECHNICAL AND METHODOLOGICALincrease from 10 to 30%, thus reducing the effective
TROUBLE SPOTSclearance by about 25%. In clinical practice, the negative
Technical and methodological problems that are com-effect of recirculation can be prevented thanks to a pro-
gram including periodical physical examinations, dy- monly encountered in the dialysis practice may alter the
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Fig. 6. Flow chart for a response to an unex-
pectedly reduced dialysis efficiency and to dis-
crepancies between prescribed and delivered
dialysis doses.
results of UKM and the prescription or delivery of the events intervene: (1) the compensation of urea concen-
trations gradients occurring during dialysis between thedialysis therapy. The most common are incorrect sam-
pling methods: (1) Dilution with saline solution of the intracellular and extracellular pool and (2) the restora-
tion of an adequate blood flow in tissue district underper-sample drawn immediately after the start of treatment
will underestimate the Kt/V. (2) Samples drawn before fused during the treatment because of a maldistribution
in the regional blood flow.the dialysis end or in the minutes following the end may
affect the UKM parameters. (3) The postdialysis blood Moreover, a correct sample, representative of the ac-
tual final urea concentration, must be drawn 30 or 60urea concentration determination is subject to error be-
cause of potential access recirculation, to the ever-pres- minutes from the end of dialysis [31]. Delaying each
patient’s dialysis on a repeated routine basis is not feasi-ent urea rebound, to dilution with solutions often used
at the end of dialysis, or to measurement inaccuracy by ble in most dialysis centers. Smye et al have suggested
a specific formula that permits an estimatation of theclinical laboratories more frequently observed for low
concentrations. In addition, blood drawn from the ve- equilibrated urea concentration using a blood sample
taken 80 minutes following the start of dialysis [31].nous instead of the arterial line is a likely event. Wrongful
measures of the final urea concentration will theoreti- Daugirdas [17] and Garred et al (abstract; ibid) have
proposed algorithms that take into account the inter-cally overestimate Kt/V, and the protein catabolic rate
while they can underestimate the TAC urea [12]. (4) compartment transfer coefficient, the effective urea vol-
ume, and the regional blood flow model. The use ofPostdialysis urea rebound is related to a number of fac-
tors [30]: access recirculation occurring in a time of ap- urea sensors, particularly for those placed in the blood
ultrafiltrate, provides current and extrapolated values forproximately 10 seconds, cardiopulmonary recirculation
over a period of 2 minutes, and the re-equilibrium effects Ceq and Kt/V corrected for double-pool urea kinetics.
However, apart from these conceptual and method-that diminish in 30 to 60 minutes. Re-equilibrium is, in
turn, a complex phenomenon in which the following ological problems, technical problems may also reduce
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Fig. 7. Determinants of dialysis adequacy.
dialysis efficiency. Miscalibration of the roller pump may phenomenon. The behavioral aspects may concern the
concession of late arrivals and premature dialysis inter-alter the actual flow, while the read-out display may
continue to give acceptable values. However, even with ruptions.
Instead, the discovery of the responsible factors fora well-calibrated pump, the high blood flows may repre-
sent a risk of inaccuracy. The reason in these cases may low efficiency in an individual patient may be extremely
complex. The patient may be deliberately noncompliantbe the development of high negative pressures within
the blood tubing [33]. After each stroke of the occlusive or unstable from a hemodynamic point of view, with
several hypotension episodes complicating his/her dial-roll pump, the pump segment of the arterial line must
recoil from a flattened to a rounded configuration. This ysis session. The hypotension may result in reducing the
effective clearance and urea removal (Fig. 3).leads to the filling of the pump segment with blood just
Insufficient anticoagulation regimens may induce par-pushed into the arterial line after the pump. The result
tial or complete hollow fiber coagulation. Alterations inis an unpredictable reduction in the actual blood flow
reprocessing procedures (abstract; Leypoldt et al, J Amthrough the filter. This effect is more or less evident on
Soc Nephrol 6:605, 1995) or problems in blood lines,the basis of the blood line characteristics, composition,
needles, or the dialysis machine may negatively influenceelasticity and dynamic compliance.
dialysis efficiency. However, very often the problem
arises from the vascular access. High blood flows and
PROBLEM SOLVING pressures in the extracorporeal circuit may generate con-
The flow chart in Figure 6 represents a guideline for tinuous alarms and time-outs, thus reducing the total
the identification of and solution to the problems oc- blood volume cleared. The surveillance of the temporal
curring in day-to-day dialysis practice. changes in the pressure values in the arterial and venous
The finding of an unexpectedly low efficiency may lines and the periodical recirculation measurement may
concern several patients or just be limited to a single prevent lapses in efficiency. A 10 to 15% recirculation
patient. In the former case, the reason may be of a techni- requires a review of needle placement. As a first ap-
cal or “behavioral” kind. Inadequate calibration of the proach, an increase in the physical separation between
blood and dialysate pumps or defects in manufacturing arterial and venous needles can be made. If the problem
persists, a fistulogram or an echo-Doppler of the accessblood tubings or needles may be responsible for a diffuse
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should be performed. Urea online monitoring by appro- moved urea,” is only one piece in the jigsaw, including
priate sensors may easily reveal any abnormalities, and acidosis correction, the achievement of dry weight, fluid
sometimes analysis with urea sensors may suggest the and electrolyte homeostasis, biocompatibility, anemia
actions to adopt in order to offset the incumbent prob- correction and treatment schedule and duration (Fig. 7).
lems [24, 29]. Furthermore, better blood pressure control and im-
When an accurate analysis does not reveal the factor proved nutritional intake should also come into the big
contributing to dialysis inefficiency, an increase in dial- picture as key elements [35].
ysis dose has to be considered (Fig. 6). This can be
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